- Weave, a Lehi, Utah-based developer of patient communications software focused on the dental and optometry market, raised $70 million in Series D funding at a valuation of $970 million. Tiger Global Management led the round, and was joined by investors including Catalyst Investors, Bessemer Venture Partners, Crosslink Capital, Pelion Venture Partners and LeadEdge Capital.
- Aviatrix, a Sherwood, Ore.-based provider of networking and security services for the multi-cloud enterprise, raised $40 million in Series C funding. CRV led the round, and was joined by investors including Formation 8, Ignition Partners and Liberty Global Ventures.
- ShiraTronics Inc, a Brooklyn Park, Minn.-based medical device company, raised $33 million in Series A funding. USVP, Amzak Health and Strategic HealthCare Investment Partners led the round, and were joined by investors including Aperture Ventures and LivaNova PLC.
- 1906, a Denver-based cannabis brand, raised $18 million in funding. Navy Capital led the round.
- Young Alfred, a New York City and Philadelphia-based home insurance shopping platform, raised $10 million in funding. Gradient Ventures led the round with participation from Pear Ventures, ERA and Newfund Capital.
- Own Up, a Boston-based software provider that enables residential lending from various lenders, raised $8.5 million in Series A funding. Link Ventures led the round.
- Picus Security, a San Francisco-based cybersecurity firm, raised $5 million in Series A funding. Earlybird led the round.
- Shiru, an Oakland, Calif.-based provider of proteins for food applications, raised $3.5 million in seed funding. Lux Capital led the round.
- EnsureDR, a Los Angeles-based disaster recovery readiness platform, raised $2.5 million in Series A funding. Awz Ventures led the round.
- Aspireship, a Scottsdale, Ariz.-based experiential professional development and career matching platform, raised $1.4 million in pre-seed funding. Story Ventures led the round, and was joined by investors including TDF Ventures, Mana Ventures, Upfront Ventures Community Fund, Supernode Ventures, and Capital Factory.
PRIVATE EQUITY DEALS
- SMP Pharmacy Solutions, a portfolio company of Galen Partners, acquired Northridge Plaza Pharmacy, a California-based pharmacy specializing in reproductive care. Financial terms weren't disclosed.
- XLerate Group, which is backed by Huron Capital, acquired Columbus Fair Auto Auction, a Columbus, Ohio-based auction that operates an 11-lane arena, reconditioning facility, body shop, and mechanical shop. Financial terms weren't disclosed.
- Cato Research, which is backed by Water Street and JLL Partners, merged with Specialized Medical Services-oncology BV (SMS-oncology), a Netherlands-based full-service contract research organization dedicated to the conduct of clinical oncology studies. Financial terms weren't disclosed.
- Guidepost Growth Equity invested $31 million in Green Rabbit, a Braintree, Mass.-based eCommerce cold chain logistics provider.
- LVMH has held “preliminary discussions” to buy Tiffany & Company (NYSE:TIF). LVMH had approached Tiffany with an all-cash bid of about $120 a share, which would value the company at approximately $14.4 billion, according to The New York Times. Read more.
- Prologis, Inc. (NYSE: PLD) agreed to Liberty Property Trust (NYSE: LPT) in an all-stock transaction, valued at approximately $12.6 billion, including debt.
- Q&K International Group, a Shanghai-based apartment rental platform in China, plans to raise $94 million in an IPO of 5.2 million ADSs priced at $17 to $19 apiece. The firm posted revenue of $129.6 million in 2018 and loss of $72.8 million. It plans to list on the Nasdaq as “QK.” Read more.
- Galera Therapeutics, a Malvern, Pa.-based firm focused on reducing toxicity during radiotherapy, now plans to raise $75 million in an IPO of 5 million shares priced at a range of between $14 to $16. It has yet to post a revenue and posted losses of $30 million in 2018. New Enterprise Associates (20.4% pre-offering), Novartis Bioventures (17%), and Novo Nordisk (15%) back the firm. It plans to list on the Nasdaq as “GRTX.” Read more.
- 89bio, a San Francisco-based biotech focused on metabolic diseases, plans to raise $70.4 million in an IPO of 4.4 million shares priced at a range of between $15 to $17. It has yet to post a revenue and posted losses of $16.2 million in 2018. OrbiMed (41.2% pre-offering), Longitude Venture Partners (24.9%), and RA Capital (21.6%) back the firm. It plans to list on the Nasdaq as “ETNB.” Read more.
- Sprout Social, a Chicago-based platform focused on social media for businesses, filed to raise $100 million in an IPO. It posted revenue of $78.8 million in 2018 and loss of $20.8 million. Goldman Sachs (35.5% pre-offering), NEA (30.9%), and Lightbank (21%) back the firm. It plans to list on the Nasdaq as “SPT.” Read more.
- Baxter International, Inc. (NYSE:BAX) acquired Cheetah Medical, a Newton Center, Mass.-based provider of non-invasive fluid management monitoring technologies, for $190 million up front cash consideration, with potential for an additional $40 million based on milestones. The seller was HighCape Capital.
FIRMS + FUNDS
- Carlyle Group, a Washington D.C.-based investment firm, raised 6.4 billion euros ($7.1 billion) for its fifth European buyout fund, according to Bloomberg. Read more.
- Lightspeed Venture Partners hired Mercedes Bent, James Ephrati, Anoushka Vaswani and Rytis Vitkauskas as partners.
IF YOU LIKE THIS EMAIL...
Share today’s Term Sheet with a friend.
Did someone share this with you? Sign up here. For previous editions, click here.
For even more, check out Data Sheet, Fortune's daily newsletter on the latest in tech news. Sign up here.